817-71-0

Basic information

• Product Name: 2-Pentanone, 1-bromo-
• Synonyms: 2-Pentanone, 1-bromo-;1-Bromopentan-2-one
• CAS NO: 817-71-0
• Molecular Formula: C₅H₉BrO
• Molecular Weight: 165.03
• Mol File: 817-71-0.mol
• Article Data: 16

Chemical Properties

• Boiling Point: 92.0-92.5 °C(Press: 50 Torr)
• Appearance: /
• Density: 1.359±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-Pentanone, 1-bromo-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pentanone, 1-bromo-(817-71-0)
• EPA Substance Registry System: 2-Pentanone, 1-bromo-(817-71-0)

Safety Data

• Hazardous Substances Data: 817-71-0(Hazardous Substances Data)

Upstream product

• 109-67-1 1-penten 
• 1271-66-5 dimethyltitanocene 
• 760-79-2 N,N-dimethylbutyramide 
• 7732-18-5 water 
• 7726-95-6 bromine 
• 107-87-9 2-Pentanone 
• 186581-53-3 diazomethane 
• 5856-82-6 butyryl bromide 

Downstream Products

• 816-21-7 1,3-dibromo-pentan-2-one 
• 103603-78-7 1-anilino-2-pentanone 
• 114432-24-5 2-n-Propyl-1-(4-tosyloxybenzenesulphonyl)indolizine 
• 102670-63-3 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-(pentan-2-on-1-yl)oxybenzamide 
• 97600-08-3 2-amino-N-methyl-4-propyloxazole-5-carbothioamide 
• 97600-10-7 2-amino-4-propyl-N-phenyloxazole-5-carbothioamide 
• 97600-09-4 N-phenyl-N'-(4-propyloxazol-2-yl)thiourea 
• 36724-25-1 3-propylbenzofuran 
• 103603-81-2 1-phenoxy-2-pentanone 
• 87034-17-1 1-phenoxy-2-pentanol 
• 1166403-28-6 (S)-1-(phenylsulfonyl)pentan-2-ol 
• 97364-04-0 1-(phenylsulfonyl)-2-pentanol 
• 131309-93-8 1-(phenylsulfonyl)pentan-2-one 

Relevant articles and documents

COMPLEMENT MODULATORS AND RELATED METHODS

The present disclosure presents compounds and compositions that interact with complement components. Some compounds inhibit complement activity. Included are small molecule compounds and compositions that function as C5 inhibitor compounds. Methods for inhibiting complement activity and methods of treating complement-related indications with the C5 inhibitor compounds and compositions are provided.

VISUAL CYCLE MODULATORS

A method of treating an ocular disorder in a subject in need thereof includes administering to the subject a therapeutically effective amount of a retinal sequestering compound of formula (I).

INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL

The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential Al ion channel (TRPA1).